Shopping Cart
- Remove All
- Your shopping cart is currently empty
CBR-470-2, a glycine-substituted analog, activates NRF2 signaling, making it valuable for investigating glycolysis modulation in scientific research [1].
Pack Size | Price | Availability | Quantity |
---|---|---|---|
5 mg | $456 | 7-10 days |
Description | CBR-470-2, a glycine-substituted analog, activates NRF2 signaling, making it valuable for investigating glycolysis modulation in scientific research [1]. |
In vitro | CBR-470-2 (1-10 μM; 24 h) upregulates NRF2-responsive genes NQO1 and HMOX1 in epidermal keratinocytes and dermal fibroblasts[1]. |
In vivo | CBR-470-2 (50 mg/kg; p.o. twice daily for 10 days) induces activation of NRF2 signaling in vivo. Animal Model: Balb/C mice (5-week old) exposed to UVB. |
Molecular Weight | 402.26 |
Formula | C12H13Cl2NO6S2 |
Cas No. | 2416095-00-4 |
Relative Density. | 1.71 g/cm3 (Predicted) |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | |||||||||||||||||||||||||||||||||||
Solubility Information | DMSO: 200 mg/mL (497.18 mM) | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
|
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.